Insider Trading activities at Cpex Pharmaceuticals, Inc. (CPEX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cpex Pharmaceuticals, Inc. (CPEX) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cpex Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1418919.

Total stock buying since 2011: $0.
Total stock sales since 2011: $0.
Total stock option exercises since 2011: $0.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


4 insiders reported insider trading activities at Cpex Pharmaceuticals, Inc. (CPEX):
Insider trading activities of Sedor John A
Insider trading activities of Berman Lance
Insider trading activities of Bergenhem Nils
Insider trading activities of Hebert Robert P

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Cpex Pharmaceuticals, Inc. (CPEX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2011 0 $0 0 $0 277,886 $0

Table 2. Monthly summary of insider trading at Cpex Pharmaceuticals, Inc. (CPEX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-04 0 $0 0 $0 277,886 $0

Table 3. Detailed insider trading at Cpex Pharmaceuticals, Inc. (CPEX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-04-05 Bergenhem Nils (Chief Scientific Officer) Option Ex 17,500 .00 0
2011-04-05 Berman Lance (Chief Medical Officer) Option Ex 48,306 .00 0
2011-04-05 Hebert Robert P (Chief Financial Officer) Option Ex 65,205 .00 0
2011-04-05 Sedor John A (CEO & President) Option Ex 146,875 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of CPEX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cpex Pharmaceuticals, Inc. (symbol CPEX, CIK number 1418919) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.